
Xywav
My Prescription
Payment
Select pharmacy



$7,283.60
$30.00 due at pharmacy
$7,283.60 - $30.00 = $7,253.60
$7,253.60 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$7,283.60
Print or send this coupon to your phone
About Xywav
Drug Details
Xywav is a medication primarily used to manage narcolepsy, a condition characterized by excessive daytime sleepiness and sudden muscle weakness known as cataplexy. It is also approved for the treatment of idiopathic hypersomnia (IH) in adults. Xywav contains a combination of calcium, magnesium, potassium, and sodium oxybates and functions as a central nervous system depressant. While the precise mechanism is not fully understood, it is believed to increase the activity of gamma-aminobutyric acid (GABA) in brain areas responsible for regulating sleep and wakefulness. The medication is typically administered orally in liquid form, twice nightly for narcolepsy, with some individuals with IH taking it once per night. Potential side effects include headache, nausea, and dizziness. Always consult a healthcare professional before starting any new treatment.
Price history for Xywav
1 Bottle, 180ML of 500MG/ML
Average retail price for Xywav
Average SaveHealth price for Xywav
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Xywav dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 180ML of 500MG/ML | 1 Bottle | $7,283.60 | $7,283.60 |
| 180ML of 500MG/ML | 2 Bottles | $14,559.20 | $7,279.60 |
| 180ML of 500MG/ML | 3 Bottles | $21,834.80 | $7,278.27 |
Xywav FAQs
XYWAV is a medication used to treat cataplexy or excessive daytime sleepiness in patients with narcolepsy. It works by affecting certain neurotransmitters in the brain to help regulate sleep-wake cycles.
Yes, XYWAV is classified as a controlled substance. It is listed under Schedule III of the Controlled Substances Act in the United States.
XYWAV (calcium, magnesium, potassium, and sodium oxybates) is used to treat idiopathic hypersomnia by helping to improve wakefulness and reduce excessive daytime sleepiness. It works by modulating neurotransmitter activity in the brain, which can help regulate sleep-wake cycles and improve overall sleep quality. This can lead to increased alertness and better functioning during the day for individuals with idiopathic hypersomnia.
Xyrem and XYWAV are both medications used to treat narcolepsy, specifically for cataplexy and excessive daytime sleepiness. The primary difference between the two is their formulation. Xyrem contains sodium oxybate, while XYWAV is a lower-sodium formulation that includes a combination of calcium, magnesium, potassium, and sodium oxybates. This difference in formulation makes XYWAV a potentially better option for patients who need to manage their sodium intake.
Xywav is not a stimulant. It is a central nervous system depressant used to treat cataplexy or excessive daytime sleepiness in patients with narcolepsy.